JBHT
38
3
UAL
57
6
MMC
41
2
PSX
50
5
IR
54
7
HIG
58
7
BF.B
50
4
USB
53
3
FOXA
63
7
NOC
56
2
AMG
74
6
AAL
17
3
JPM
55
3
HP
30
-2
VTR
58
3
SWK
52
3
PNW
53
4
NEM
59
7
NWSA
70
8
GWW
25
2
JBHT
38
3
UAL
57
6
MMC
41
2
PSX
50
5
IR
54
7
HIG
58
7
BF.B
50
4
USB
53
3
FOXA
63
7
NOC
56
2
AMG
74
6
AAL
17
3
JPM
55
3
HP
30
-2
VTR
58
3
SWK
52
3
PNW
53
4
NEM
59
7
NWSA
70
8
GWW
25
2
Financhill
Back

Philip Morris International Vs. Monopar Therapeutics Industry Stock Comparison

Sell
35

PM
Philip Morris International

Last Price:
$163.78
Seasonality Move:
-1.46%
Buy
53

MNPR
Monopar Therapeutics

Last Price:
$39.59
Seasonality Move:
62.15%
Sell
35
Philip Morris International (PM) is a Sell

Is Philip Morris International a Buy, Sell or Hold?

  • The current Philip Morris International [PM] share price is $162.99. The Score for PM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • PM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $41.75. The Score for MNPR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PM Stock Price Chart

What is Philip Morris International's stock price today?

  • The Philip Morris International share price today is $162.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PM is experiencing slight selling pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $41.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

PM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 40.24 Buy
Relative Strength Index (14 RSI): 36.59 Sell
Chaikin Money Flow: -2342103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (164.14 - 181.48) Sell
Bollinger Bands (100): (158.15 - 180.51) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.28 Buy
Relative Strength Index (14 RSI): 51.57 Buy
Chaikin Money Flow: 17199 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.3 - 45.36) Buy
Bollinger Bands (100): (33.01 - 42.25) Buy

PM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 161.84 Buy
20-day SMA: 171.23 Sell
50-day SMA: 177.09 Sell
200-day SMA: 150.48 Buy
8-day EMA: 116.63 Buy
20-day EMA: 64.18 Buy
50-day EMA: 29.55 Buy
200-day EMA: 7.95 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.06 Sell
20-day SMA: 42.76 Sell
50-day SMA: 37.59 Buy
200-day SMA: 32.17 Buy
8-day EMA: 29.81 Buy
20-day EMA: 16.45 Buy
50-day EMA: 7.58 Buy
200-day EMA: 2.04 Buy

Philip Morris International Earnings Growth & PM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.17 per share, an increase this year of $1.04 per share, and an increase next year of $0.82 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.48 per share.

Philip Morris International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):